United Therapeutics Corp.
(NASDAQ : UTHR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -3.05%51.440.0%$776.26m
GWPHGW Pharmaceuticals Plc 0.07%215.166.1%$387.19m
HZNPHorizon Therapeutics Plc -3.70%91.955.6%$196.23m
JAZZJazz Pharmaceuticals Plc -0.74%172.222.3%$187.07m
VRXValeant Pharmaceuticals International, Inc. 0.84%31.3114.1%$184.23m
BHCBausch Health Cos., Inc. 0.84%31.310.0%$142.40m
CTLTCatalent, Inc. -1.92%112.942.1%$111.56m
ARGXargenx SE 0.86%339.800.0%$83.56m
ICLRICON plc -3.25%186.154.2%$76.76m
TNXPTonix Pharmaceuticals Holding Corp. 1.22%1.270.2%$72.74m
ZYNEZynerba Pharmaceuticals, Inc. -8.61%4.586.0%$59.64m
AMRNAmarin Corp. Plc -1.92%7.161.5%$56.31m
PRGOPerrigo Co. Plc -1.52%41.036.8%$51.47m
PBHPrestige Consumer Healthcare, Inc. 0.02%42.084.0%$48.38m
UTHRUnited Therapeutics Corp. -1.81%170.5614.1%$45.27m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.